BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/28/2021 8:20:27 AM | Browse: 44 | Download: 19
Publication Name World Journal of Clinical Oncology
Manuscript ID 65669
Country/Territory United States
Category Oncology
Manuscript Type Review
Article Title Cellular based treatment modalities for unresectable hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Konstantinos Damiris, Hamza Abbad and Nikolaos Pyrsopoulos
Funding Agency and Grant Number
Corresponding Author Nikolaos Pyrsopoulos, FAASLD, AGAF, FACG, MD, PhD, Professor, Department of Medicine, Division of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, 185 South Orange Ave, Newark, NJ 07103, United States. pyrsopni@njms.rutgers.edu
Key Words Hepatocellular carcinoma; Immunotherapy; Immune cells; Adoptive T cell therapy; Chimeric antigen receptor-T cell; Clinical trials
Core Tip Over the recent years investigation for safe and effective treatments for unresectable hepatocellular carcinoma (HCC) has shifted focus from various chemotherapeutic agents to immune based therapy. Although far from being finalized, immune cell-based therapy has shown efficacy in a variety of clinical trials, indicating possible future utilization alone or in combination for the prevention and treatment of HCC.
Citation Damiris K, Abbad H, Pyrsopoulos N. Cellular based treatment modalities for unresectable hepatocellular carcinoma. World J Clin Oncol 2021; In press
Received
2021-03-12 14:18
Peer-Review Started
2021-03-12 14:36
To Make the First Decision
Return for Revision
2021-04-06 03:31
Revised
2021-04-19 19:59
Second Decision
2021-04-28 07:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-04-28 08:20
Articles in Press
2021-04-28 08:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-05-10 09:52
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Chen-Chen Gao
Reviewer Code 05261716, 05172397, 02569794, 02569794, and 05261716
Editorial Director
Journal Chief Editor
Company Chief Editor Ze-Mao Gong
Language Editor
Production Editor Ying-Yi Yuan
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Manuscript File 65669_Auto_Edited-ZMG.docx
Answering Reviewers 65669-Answering reviewers.pdf
Audio Core Tip 65669-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 65669-Conflict-of-interest statement.pdf
Copyright License Agreement 65669-Copyright license agreement.pdf
Peer-review Report 65669-Peer-review(s).pdf
Scientific Misconduct Check 65669-Scientific misconduct check.pdf
Scientific Editor Work List 65669-Scientific editor work list.pdf